SUSTINEX 30MG TABLET

Indications

• Major depressive disorder
• Generalized anxiety disorder
• Panic disorder
• Obsessive-compulsive disorder
• Post-traumatic stress disorder

Dosage

Children: Refer to appropriate pediatric dosing guidelines and local prescribing information, as doses may differ significantly based on age, weight, and clinical condition.

Adults: Refer to established clinical guidelines and local prescribing information for appropriate dosing. Dosing regimens may vary based on the specific condition being treated.

Mechanism of action

Dapotexine functions primarily by selectively inhibiting the reuptake of serotonin (5-HT) in the synaptic cleft, thereby increasing the availability of serotonin to bind to its receptors. This action enhances serotonergic neurotransmission, which is believed to contribute to its antidepressant and anxiolytic effects. Additionally, it may influence other neurotransmitter systems, including norepinephrine and dopamine, although its primary mechanism is through serotonin modulation.

Pharmacodynamics

The pharmacodynamics of dapotexine involve its interaction with serotonin transporters, leading to increased serotonin levels in the synaptic cleft. This increase is associated with improved mood and reduced anxiety. The onset of action typically takes several weeks, as adaptations in neurotransmitter systems and receptor sensitivity occur over time. Side effects may include gastrointestinal disturbances, sleep changes, and sexual dysfunction, which are common with SSRIs.

Pharmacokinetics

Dapotexine is absorbed after oral administration, with peak plasma concentrations typically achieved within a few hours. It undergoes hepatic metabolism, potentially involving cytochrome P450 enzymes. The drug's elimination half-life allows for once-daily dosing, and it is excreted primarily through the kidneys. Variability in metabolism may occur due to genetic factors or concomitant medications.

Contra-indications

• Hypersensitivity to dapotexine or any of its components
• Severe renal impairment
• Severe hepatic impairment

Adverse effects

• Nausea
• Dizziness
• Headache
• Fatigue
• Hypoglycemia
• Gastrointestinal disturbances

Interactions

• May interact with other medications that affect blood glucose levels
• Caution is advised when used with other drugs that can cause dizziness or hypotension

Precautions

• Use with caution in patients with a history of cardiovascular disease
• Monitor renal function periodically
• Assess for signs of hypoglycemia, particularly in vulnerable populations

Pregnancy

Safety during pregnancy has not been established; use only if benefits outweigh risks.

Breast-feeding

Caution is advised; the effects on breastfed infants are unknown.

Storage

Store at room temperature, away from moisture and light.

Formulations

• Tablets
• Oral solution